Codice QR

Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections

Shahid Akhtar,1 Birgitte Berg,2 Johan Medina,3 Maya Nicole Gonczi,4 Sophie Hamilton,5 Emily Hildebrand,4 Nicky Kelepouris,6 Jesper Skov Neergaard,7 Claus Sværke,8 Gitte Ter-Borch,2 Niklas Kahr Rasmussen3 1Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark; 2Clinical Operations, Obesity, Liv...

Descrizione completa

Salvato in:
Autori principali: Akhtar S, Berg B, Medina J, Gonczi MN, Hamilton S, Hildebrand E, Kelepouris N, Neergaard JS, Sværke C, Ter-Borch G, Rasmussen NK
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2024-10-01
Serie:Medical Devices: Evidence and Research
Soggetti:
growth hormone deficiency
long-acting growth hormone
device preference
ease of use
somapacitan
somatrogon
Accesso online:https://www.dovepress.com/patients-with-growth-related-disorders-and-caregivers-prefer-the-somap-peer-reviewed-fulltext-article-MDER
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi